Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03743051

Conditions
Body Weight, Body Weight Changes, Bronchial Neoplasms, +16 more
Locations
  • Chen Tucson, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • The Oncology Insitute of Hope and Innovation Riverside, California, United States
  • Hartford HealthCare Cancer Institute at the Hospital of Central Connecticut Plainville, Connecticut, United States
View all 72 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03743064

Conditions
Body Weight, Body Weight Changes, Bronchial Neoplasms, +16 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Pacific Cancer Medical Center, Inc Anaheim, California, United States
  • CBCC Global Research Inc Bakersfield, California, United States
  • Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc. Fountain Valley, California, United States
View all 65 locations
View Trial Details
Completed

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

NCT04642469

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non- Small Cell Lung, +8 more
Locations
  • Research Site Long Beach, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Daytona Beach, Florida, United States
  • Research Site Gainesville, Florida, United States
View all 115 locations
View Trial Details
Completed

A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

NCT03693300

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Gainesville, Georgia, United States
  • Research Site Knoxville, Tennessee, United States
  • Research Site Créteil, France
  • Research Site Paris, France
View all 28 locations
View Trial Details
Completed

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study

NCT03950674

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • National Hospital Organization Nagoya Medical Center ( Site 0324) Nagoya, Aichi-ken, Japan
  • Kurume University Hospital ( Site 0326) Kurume, Fukuoka, Japan
  • Hyogo Cancer Center ( Site 0325) Akashi, Hyōgo, Japan
  • Kanazawa University Hospital ( Site 0328) Kanazawa, Ishikawa-ken, Japan
View Trial Details
Completed

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

NCT03847519

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Illinois CancerCare, P.C. Peoria, Illinois, United States
View Trial Details

Related conditions